Amag Pharmaceuticals (AMAG) 23.66 $AMAG AMAG

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amag Pharmaceuticals (AMAG) 23.66 $AMAG

AMAG Pharmaceuticals to Present at Upcoming Investor Conference
GlobeNewswire - Thu Sep 01, 8:35AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 10:30 a.m. EDT.
AMAG: 23.66 (-0.05), MS: 31.89 (-0.02)

AMAG Pharmaceuticals Rises 1.00% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 22, 4:39PM CDT
AMAG Pharmaceuticals (NASDAQ:AMAG) traded in a range yesterday that spanned from a low of $25.61 to a high of $26.83. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $25.94 on volume of 347,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
AMAG: 23.66 (-0.05)

After Yesterday's Decline of 8.29%, AMAG Pharmaceuticals Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 10, 1:51PM CDT
AMAG Pharmaceuticals (NASDAQ:AMAG) traded in a range yesterday that spanned from a low of $22.50 to a high of $25.75. Yesterday, the shares fell 8.3%, which took the trading range below the 3-day low of $25.10 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
GlobeNewswire - Tue Aug 09, 6:31AM CDT
Total GAAP quarterly product and service revenues increased approximately 50% to $127 million
AMAG: 23.66 (-0.05)

Shares of AMAG Up 27.0% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Aug 03, 1:12PM CDT
SmarTrend identified an Uptrend for AMAG Pharmaceuticals (NASDAQ:AMAG) on May 31st, 2016 at $21.22. In approximately 2 months, AMAG Pharmaceuticals has returned 26.96% as of today's recent price of $26.94.
AMAG: 23.66 (-0.05)

How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON
PR Newswire - Fri Jul 29, 7:50AM CDT
The Healthcare sector remains one of the most stable industries in the market, unfazed by economic conditions and uncertainties. While the industry faces issues with cost pressures, ransomware risks, and existing policies, several companies remain unscathed and continue to impress with significant returns. Stocks to evaluate today on Stock-Callers.com are AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), Neogenomics Inc. (NASDAQ: NEO), and ICON PLC (NASDAQ: ICLR). Learn more about these stocks by accessing their free notes at:
NEO: 8.00 (+0.05), AMAG: 23.66 (-0.05), IDXX: 114.09 (+0.93), ICLR: 77.14 (+0.29)

Should You Get Rid of AMAG Pharmaceuticals (AMAG) Now?
Zacks Equity Research - Zacks Investment Research - Wed May 25, 7:54AM CDT
AMAG Pharmaceuticals has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
ANIP: 59.86 (-1.56), AMAG: 23.66 (-0.05)

Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
PR Newswire - Thu May 19, 7:50AM CDT
The equities market is never short of surprises, and one sector that is always abounding of surprises is without doubt the Healthcare space. ActiveWallSt.com has uncovered four stocks in the Healthcare sector ahead of today's trading session: Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), and Atossa Genetics Inc. (NASDAQ: ATOS). Sign up for your complimentary alerts at:
ATOS: 2.42 (+0.01), AMAG: 23.66 (-0.05), IDXX: 114.09 (+0.93), ALKS: 45.12 (+0.38)

New Strong Sell Stocks for May 19th
Swarup Gupta - Zacks Investment Research - Thu May 19, 7:45AM CDT
5 fresh stock additions to the Zacks Rank #5 (Strong Sell) List for Thursday
UEPS: 9.69 (+0.21), PLM: 0.87 (-0.02), MTGE: 17.34 (+0.33), WY: 31.85 (-0.02), AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals Announces 2016 Analyst Day
GlobeNewswire - Thu May 19, 7:00AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today announced that it will host an Analyst Day in New York City on Wednesday, June 1, 2016. The event will start at 8:30 a.m. and conclude at approximately 12:00 p.m. ET.
AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals Has Returned 19.3% Since SmarTrend Recommendation (AMAG)
Comtex SmarTrend(R) - Wed May 18, 1:21AM CDT
SmarTrend identified a Downtrend for AMAG Pharmaceuticals (NASDAQ:AMAG) on May 3rd, 2016 at $23.23. In approximately 2 weeks, AMAG Pharmaceuticals has returned 19.29% as of today's recent price of $18.75.
AMAG: 23.66 (-0.05)

Downgrade Alert for AMAG Pharmaceuticals (AMAG)
Comtex SmarTrend(R) - Thu May 05, 3:36AM CDT
AMAG Pharmaceuticals (NASDAQ:AMAG) was downgraded from Outperform to Market Perform at Raymond James today. The stock closed yesterday at $19.55 on volume of 4.3 million shares, above average daily volume of 1.0 million. AMAG Pharmaceuticals share prices have moved between a 52-week high of $77.73 and a 52-week low of $20.22 and closed yesterday at -3% above that low price at $19.55 per share. Over the past week, the 200-day moving average (MA) has gone down 2.2% while the 50-day MA has declined 0.7%.
AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results
GlobeNewswire - Tue May 03, 6:00AM CDT
-- First quarter 2016 non-GAAP product revenue increased 52% to $117.6 million
AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals to Participate in the Deutsche Bank 41st Annual Healthcare Conference
GlobeNewswire - Wed Apr 27, 7:02AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in an analyst-led fireside chat at the Deutsche Bank 41 Annual Healthcare Conference on Wednesday, May 4, 2016 at 8:40 a.m. ET in Boston.
DB: 14.90 (+0.21), AMAG: 23.66 (-0.05)

AMAG Pharmaceuticals to Host Conference Call on May 3, 2016 at 8:00 a.m. ET to Discuss Financial Results for the First Quarter Ended March 31, 2016
GlobeNewswire - Thu Apr 21, 7:03AM CDT
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced it will report unaudited consolidated financial results for the first quarter ended March 31, 2016 before the U.S. financial markets open on Tuesday, May 3, 2016. The announcement will be followed by a conference call and webcast with slides at 8:00 a.m. ET, during which management will provide an update on recent developments and discuss the company's first quarter 2016 financial and operating results.
AMAG: 23.66 (-0.05)

Gilead Presents Multiple HCV and HBV Data at Liver Congress
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 12:59PM CDT
Gilead Sciences (GILD) presented results from several phase II and phase III studies for the treatment of HCV and HBV infection at The International Liver Congress.
EBS: 26.90 (+0.49), GILD: 76.89 (-0.53), AMAG: 23.66 (-0.05), ANIK: 47.89 (-0.05)

Synta Stock Up on Merger Deal with Madrigal Pharmaceuticals
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 10:30AM CDT
Synta (SNTA) announced all-stock merger transaction with Madrigal Pharmaceuticals to create a company focused on cardiovascular-metabolic diseases and NASH.
SNTA: 0.34 (+0.07), EBS: 26.90 (+0.49), ICPT: 150.74 (+3.92), AMAG: 23.66 (-0.05)

Intrexon (XON) Gains Following Deals with Two Startups
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 2:40PM CDT
Intrexon's (XON) shares gained after the company announced exclusive channel collaborations with a couple of Harvest Intrexon Enterprise Fund-backed startups.
EBS: 26.90 (+0.49), FCSC: 0.89 (-0.01), XON: 25.33 (+0.04), AMAG: 23.66 (-0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 61

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
Dallas College Recognition Signals Workforce Value

Updated Category News Views 49

Economic mobility rarely arrives with brass bands, but it can show up in a community-college ranking. Dallas College has landed on TIME and Statista's inaugural America’s Best Community Colleges 2027 list, one of 250 schools selected from roughly 1,100 nationwide. For a region that keeps talking about talent pipelines, this is a useful piece of outside validation—not...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Lennar's 6.73% Slide Puts Disclosure Claims in Focus

Updated Category News Views 12

A homebuilder can survive ugly margins; murky demand signals are another beast entirely. Lennar is staring at a securities class action after a bruising run of disclosures and market reactions, and the central issue is not whether housing got tougher. Everybody with a pulse knew rates were squeezing buyers. The issue is whether NYSE:LEN gave investors a sufficiently clear...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Duetti, CesiumAstro, and a Busy NYSE Capital Morning

Updated Category News Views 78

Three very different piles of money are jamming up the November 20 NYSE slate, and that contrast is the whole point. Private music catalogs, space-and-defense communications, and a new stock-and-bond ETF do not belong in the same bucket. Yet all three are competing for investor attention before the opening bell, alongside Danaos Corporation's 20th listing anniversary....

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 80

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Nansha's Trade Pitch Has Numbers, but Questions Remain

Updated Category News Views 84

A Chilean cherry spending 22 days at sea can tell an investor plenty about where Guangzhou's Nansha District wants to sit in Asia-Pacific commerce. Not glamorous, no. But trade infrastructure rarely is until volumes pile up, routes deepen, and somebody else finds they cannot easily replicate the network. Nansha is using the expected 33rd APEC Economic Leaders' Meeting in...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 100

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading

Top 5 Most Recently Viewed Articles

DatChat Receives Mexican Patent for Enhanced Privacy Solutions

Updated Category News Views 157

DatChat's Latest Patent Achievement New Brunswick, NJ - DatChat, Inc. (NASDAQ: DATS), a leading company in secure messaging and social media, has exciting news to share. Recently, the Mexican Patent office issued a Notice of Allowance for DatChat's patent application titled "Systems and Methods of Transforming Electronic Content." This development follows the company...

Continue Reading
Flora Growth Partners with Canopy to Enhance Cannabis Access

Updated Category News Views 111

Flora Growth Enters the Australian Medical Cannabis Market Flora Growth Corp (NASDAQ: FLGC) has recently taken a significant step into the Australian medical cannabis arena through its strategic partnership with Canopy Growth Corp (NASDAQ: CGC). A distribution agreement has been signed, allowing Flora's subsidiary, Australian Vaporizers, to handle the distribution of...

Continue Reading
Digital Brands Group Sets Public Offering of 11.36 Million Units

Updated Category News Views 167

Digital Brands Group Projects Strong Growth with New Offering Digital Brands Group, Inc. (OTC PINK: DBGI), a unique entity known for curating luxury lifestyle brands, has recently made headlines with their announcement regarding a public offering. This initiative, which involves an impressive volume of 11.36 million units, is set to make waves in the market. Details of...

Continue Reading
Unraveling Solana's Remarkable Rise From $11 to $166

Updated Category News Views 154

Unraveling Solana's Remarkable Rise From $11 to $166 Solana (SOL), a cryptocurrency that emerged in March 2020, has astonished investors with its dramatic increase in value. It has risen more than 15 times its initial value, predominantly bolstered by a vibrant ecosystem that has flourished around various meme coins. Jim Cramer’s Warning In 2022, Jim Cramer, a prominent...

Continue Reading
LO3 Capital Revolutionizes Travel Services with CCRA Deal

Updated Category News Views 189

LO3 Capital Makes Strategic Investment in CCRA International LO3 Capital, a dynamic private investment firm, is making waves with its recent senior debt investment in CCRA International, Inc. This relationship is pivotal for CCRA, a technology-driven travel services platform, as it progresses towards acquiring ABC Global Services. This acquisition is set to form one of...

Continue Reading